The polycystic ovary syndrome (PCOS) is the disease featured by elevated levels of
androgens, ovulatory dysfunction, and morphological abnormalities. At reproductive stage of …

BACKGROUND Here we describe the consensus guideline methodology, summarise the
evidence-based recommendations we provided to the World Health Organisation (WHO) for …

Mitochondria are known to be functional organelles, but their role as a signaling unit is
increasingly being appreciated. The identification of a short open reading frame (sORF) in …

Polycystic ovary syndrome (PCOS) is the most common ovarian disorder associated with
androgen excess in women, which justifies the growing interest of endocrinologists. Great …

BACKGROUND Polycystic ovary syndrome (PCOS) is a common endocrine disorder with
diverse reproductive and metabolic features. It is underpinned by insulin resistance that is …

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of
reproductive age, with a prevalence of up to 10%. Various diagnostic criteria have been …

Polycystic ovary syndrome (PCOS) is the most prevalent endocrinopathy among women
during reproductive age. PCOS is characterised by hyperandrogenaemia …

Polycystic ovary syndrome (PCOS) is a common hormonal condition with reproductive,
metabolic, and psychological sequelae. The Rotterdam Criteria are now internationally …

Background Multiple oral insulin-sensitizing agents, such as metformin, thiazolidinediones,
inositols, and berberine, have been proven safe and efficacious in improving the endocrine …

Context Metformin is used in pregnancy in women with gestational diabetes mellitus,
polycystic ovary syndrome (PCOS), and obesity. Metformin passes the placenta. Objective …